微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.42% | 20.85% | -53.34% | 22/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 7.33% | -4.18% | 84.63% | 25/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 3.97% | 3.12% | -11.58% | 39/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 4.49% | 36.47% | 58.66% | 27/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 2.83% | -17.73% | -63.01% | 25/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 7.65% | 27.08% | 98.7% | 22/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 3.85% | -40.68% | 17.02% | 39/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 3.29% | -36.61% | -4.36% | 34/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.44% | 52.89% | -42.86% | 22/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.02% | 142.74% | -7.24% | 39/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 6.49% | 232.82% | 25.05% | 39/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.19% | 2952.94% | 130.67% | 29/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 2.25% | 359.18% | -9.27% | 40/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 2.48% | 205.53% | 27.18% | 51/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 1.95% | 271.05% | 1047.06% | 57/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 0.17% | 122.37% | -65.31% | 61/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.49% | 1533.33% | 120.85% | 56/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | -2.35% | -571.43% | -106.14% | 61/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | -1.14% | 36.31% | -50% | 62/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | -0.76% | 53.37% | -2633.33% | 63/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.03% | 0% | 108.57% | 62/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -0.35% | -146.67% | 80.45% | 60/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | -1.79% | -338.67% | -9.82% | 64/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | -1.63% | -283.15% | -5533.33% | 62/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 0.03% | -96.74% | -96% | 58/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 0.75% | -34.21% | 0% | 56/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 0.75% | -49.32% | -15.73% | 58/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 0.89% | -35.04% | -3.26% | 60/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 0.92% | 2.22% | -19.3% | 54/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 1.14% | -33.72% | -22.97% | 56/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 1.48% | -19.13% | 8.03% | 58/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 1.37% | -8.05% | 52.22% | 57/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 0.9% | -16.67% | -47.67% | 54/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 1.72% | -80.56% | -6.01% | 60/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 1.83% | -73.28% | 22.82% | 58/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 1.49% | -73.91% | 37.96% | 57/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 1.08% | 2% | -87.8% | 47/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 8.85% | -34.4% | 29.2% | 39/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 6.85% | 2% | 19.96% | 35/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 5.71% | 2% | -57.67% | 29/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |